Google Alert - in

	in As-it-happens update ⋅ 19 August 2025
	NEWS
	A baby benefits from personalized gene editing in the clinic - Nature Nature Scientists have used a genome-editing technique called base editing to correct a mutation in a baby who had been diagnosed with a rare genetic disease ... Flag as irrelevant
	US in talks for a 10% Intel stake, White House says - Financial Times Financial Times US in talks for a 10% Intel stake, White House says. Commerce secretary Howard Lutnick 'ironing out the details' of a deal, according to Trump's ... Flag as irrelevant
	Atlassian Anchors Remote Flexibility in Structured Daily Practices Harvard Business Review In 2020, Atlassian committed to a fully distributed model, allowing employees to work from anywhere, permanently. While many tech peers later ... Flag as irrelevant
	Bishop in Indonesia calls for tourism that unites people and protects creation - Vatican News Vatican News At the opening of Festival Golo Koe 2025, Bishop Maksimus Regus urged that tourism in Indonesia's Labuan Bajo must unite communities, protect ... Flag as irrelevant
	Uncle Sam taking a stake in Intel is sane in an absurd world - Financial Times Financial Times For a president who likes to make deals, investing in the chip company makes sense. Flag as irrelevant
	EU officials should see for themselves what's happening in Gaza – POLITICO Politico.eu But that solidarity in response to Hamas's atrocities is now devolving into complicity with Isreal's atrocities. Israel's ensuing military campaign ... Flag as irrelevant
	The Nineteen-Thirties Novel That's Become a Surprise Hit in the U.K. | The New Yorker The New Yorker Set in a small village in the Bavarian Alps, Sally Carson's "Crooked Cross" presents an eerily familiar portrait of the rise of fascism, ... Flag as irrelevant
	WEB
	FaceApp PRO makes it so easy to clean up little things in my photos, whether it's something ... Instagram ... in the background or switching up my hairstyle for a different vibe ... in bio #FaceAppPartner". Flag as irrelevant
	BioMed X and Novo Nordisk Launch New Collaboration in Oral Peptide Drug Delivery BioMed X This partnership aims to address one of the most critical challenges in modern drug development: the efficient oral delivery of therapeutic peptides. Flag as irrelevant

You have received this email because you have subscribed to Google Alerts. Unsubscribe

Receive this alert as RSS feed

Send Feedback

ShareThis